catASium(R) MQF(R)Rh, 1,2-Bis[(2R,5R)-2,5-dimethyl-phospholanyl]3,3,4,4-tetrafluoro-1-cyclobutene(1,5-cyclooctadiene)rhodium(I) tetrafluoroborate
- $470 - $498.49
- Product name: catASium(R) MQF(R)Rh, 1,2-Bis[(2R,5R)-2,5-dimethyl-phospholanyl]3,3,4,4-tetrafluoro-1-cyclobutene(1,5-cyclooctadiene)rhodium(I) tetrafluoroborate
- CAS: 910048-20-3
- MF: C24H34BF8P2Rh
- MW: 650.19
- EINECS:
- MDL Number:MFCD10567388
- Synonyms:1,2-Bis[(2R,5R)-2,5-dimethylphospholano]-3,3,4,4-tetrafluoro-1-cyclobutene(1,5-cyclooctadiene)rhodium(I) tetrafluoroborate;catASium(R) MQF(R)Rh, 1,2-Bis[(2R,5R)-2,5-dimethyl-phospholanyl]3,3,4,4-tetrafluoro-1-cyclobutene(1,5-cyclooctadiene)rhodium(I) tetrafluoroborate;catASium? MQF(R)Rh
2 prices
Selected condition:
Brand
- American Custom Chemicals Corporation
- Sigma-Aldrich
Package
- 5MG
- 500mg
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberOGM0002717
- Product description1,2-BIS-[(2R,5R)-2,5-DIMETHYL-PHOSPHOLANYL]-3,3,4,4-TETRAFLUORO-1-CYCLOBUTENE(1,5-CYCLOOCTADIENE)RHODIUM-(I)-TETRAFLUOROBORATE 95.00%
- Packaging5MG
- Price$498.49
- Updated2021-12-16
- Buy
- ManufacturerSigma-Aldrich
- Product number670472
- Product description1,2-Bis[(2R,5R)-2,5-dimethylphospholano]-3,3,4,4-tetrafluoro-1-cyclobutene(1,5-cyclooctadiene)rhodium(I) tetrafluoroborate 95%
- Packaging500mg
- Price$470
- Updated2024-03-01
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
American Custom Chemicals Corporation | OGM0002717 | 1,2-BIS-[(2R,5R)-2,5-DIMETHYL-PHOSPHOLANYL]-3,3,4,4-TETRAFLUORO-1-CYCLOBUTENE(1,5-CYCLOOCTADIENE)RHODIUM-(I)-TETRAFLUOROBORATE 95.00% | 5MG | $498.49 | 2021-12-16 | Buy |
Sigma-Aldrich | 670472 | 1,2-Bis[(2R,5R)-2,5-dimethylphospholano]-3,3,4,4-tetrafluoro-1-cyclobutene(1,5-cyclooctadiene)rhodium(I) tetrafluoroborate 95% | 500mg | $470 | 2024-03-01 | Buy |
Properties
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|